Top Biotechnology companies in United States by Revenue Per Share

This ranking features the top 515 Biotechnology companies in United States ranked by Revenue Per Share, averaging a Revenue Per Share of USD 137.80, for January 15, 2025.

United States

Biotechnology

#	Name	Revenue Per Share	Reported Date	Stock Price	Change	Country
1	Cingulate Inc. 1 CING	USD 68,343.25	Sept. 30, 2023	USD 4.62	-0.22%	United States
2	Laboratory Corporation of America Holdings 2 LH	USD 150.85	Sept. 30, 2024	USD 234.50	0.17%	United States
3	Regeneron Pharmaceuticals, Inc. 3 REGN	USD 128.63	Sept. 30, 2024	USD 690.87	-3.63%	United States
4	Thermo Fisher Scientific Inc. 4 TMO	USD 110.55	Sept. 28, 2024	USD 556.99	0.27%	United States
5	Radius Health, Inc. 5 RDUS	USD 105.10	Nov. 30, 2023	USD 11.35	-0.53%	United States
6	Bio-Rad Laboratories, Inc. 6 BIO	USD 90.81	Sept. 30, 2024	USD 342.23	-2.69%	United States
7	IQVIA Holdings Inc. 7 IQV	USD 84.38	Sept. 30, 2024	USD 197.96	-3.26%	United States
8	Charles River Laboratories International, Inc. 8 CRL	USD 78.97	Sept. 28, 2024	USD 178.08	-6.34%	United States
9	Biogen Inc. 9 BIIB	USD 64.71	Sept. 30, 2024	USD 143.06	-4.74%	United States
10	Amgen Inc. 10 AMGN	USD 60.47	Sept. 30, 2024	USD 267.10	-1.14%	United States
11	United Therapeutics Corporation 11 UTHR	USD 60.24	Sept. 30, 2024	USD 364.70	0.50%	United States
12	Stryker Corporation 12 SYK	USD 57.73	Sept. 30, 2024	USD 362.80	0.50%	United States
13	Mesa Laboratories, Inc. 13 MLAB	USD 42.30	Sept. 30, 2024	USD 131.05	-0.04%	United States
14	QuidelOrtho Corporation 14 QDEL	USD 41.99	Sept. 29, 2024	USD 41.10	-7.87%	United States
15	Vertex Pharmaceuticals Incorporated 15 VRTX	USD 41.13	Sept. 30, 2024	USD 411.66	-0.41%	United States
16	Benson Hill, Inc. 16 BHIL	USD 37.62	Sept. 30, 2024	USD 1.78	4.71%	United States
17	AbbVie Inc. 17 ABBV	USD 31.41	Sept. 30, 2024	USD 175.55	-0.67%	United States
18	Fortrea Holdings Inc. 18 FTRE	USD 31.24	Sept. 30, 2024	USD 17.64	-3.66%	United States
19	Balchem Corporation 19 BCPC	USD 29.18	Sept. 30, 2024	USD 158.62	1.47%	United States
20	ANI Pharmaceuticals, Inc. 20 ANIP	USD 28.92	Sept. 30, 2024	USD 54.16	0.43%	United States
21	Illumina, Inc. 21 ILMN	USD 27.61	Sept. 29, 2024	USD 136.48	-5.37%	United States
22	Danaher Corporation 22 DHR	USD 27.24	Sept. 27, 2024	USD 237.62	-0.94%	United States
23	Lipella Pharmaceuticals Inc. 23 LIPO	USD 24.79	Sept. 30, 2024	USD 3.05	0.33%	United States
24	Corteva, Inc. 24 CTVA	USD 23.80	Sept. 30, 2024	USD 60.89	1.60%	United States
25	Bristol-Myers Squibb Company 25 BMY	USD 23.41	Sept. 30, 2024	USD 55.74	0.69%	United States
26	Gilead Sciences, Inc. 26 GILD	USD 22.69	Sept. 30, 2024	USD 91.00	1.18%	United States
27	Agilent Technologies, Inc. 27 A	USD 22.38	Oct. 31, 2024	USD 143.43	1.04%	United States
28	Bruker Corporation 28 BRKR	USD 22.12	Sept. 30, 2024	USD 61.26	-2.69%	United States
29	Revvity, Inc. 29 RVTY	USD 22.08	Sept. 29, 2024	USD 120.73	-1.61%	United States
30	Lantheus Holdings, Inc. 30 LNTH	USD 21.69	Sept. 30, 2024	USD 92.62	-2.15%	United States
31	Emergent BioSolutions Inc. 31 EBS	USD 21.46	Sept. 30, 2024	USD 9.36	-0.53%	United States
32	Orthofix Medical Inc. 32 OFIX	USD 20.70	Sept. 30, 2024	USD 17.51	0.81%	United States
33	MediciNova, Inc. 33 MNOV	USD 20.39	Sept. 30, 2023	USD 1.91	-4.02%	United States
34	Zoetis Inc. 34 ZTS	USD 20.05	Sept. 30, 2024	USD 164.41	-1.15%	United States
35	iSpecimen Inc. 35 ISPC	USD 19.23	Sept. 30, 2024	USD 2.64	-1.49%	United States
36	Incyte Corporation 36 INCY	USD 18.97	Sept. 30, 2024	USD 71.93	-0.61%	United States
37	Inotiv, Inc. 37 NOTV	USD 18.95	Sept. 30, 2024	USD 4.22	NA	United States
38	ReShape Lifesciences Inc. 38 RSLS	USD 18.68	Sept. 30, 2024	USD 4.66	-6.80%	United States
39	Globus Medical, Inc. 39 GMED	USD 18.22	Sept. 30, 2024	USD 88.18	1.15%	United States
40	Nuwellis, Inc. 40 NUWE	USD 17.57	Sept. 30, 2024	USD 1.05	3.96%	United States
41	Sarepta Therapeutics, Inc. 41 SRPT	USD 17.38	Sept. 30, 2024	USD 118.83	0.34%	United States
42	Atara Biotherapeutics, Inc. 42 ATRA	USD 17.05	Sept. 30, 2024	USD 12.31	-23.96%	United States
43	ZimVie Inc. 43 ZIMV	USD 16.53	Sept. 30, 2024	USD 13.47	-1.25%	United States
44	Alnylam Pharmaceuticals, Inc. 44 ALNY	USD 16.52	Sept. 30, 2024	USD 240.51	-6.88%	United States
45	Pacira BioSciences, Inc. 45 PCRX	USD 15.01	Sept. 30, 2024	USD 20.55	-2.74%	United States
46	Amphastar Pharmaceuticals, Inc. 46 AMPH	USD 14.89	Sept. 30, 2024	USD 38.48	1.48%	United States
47	Exact Sciences Corporation 47 EXAS	USD 14.70	Sept. 30, 2024	USD 54.20	-7.37%	United States
48	BioMarin Pharmaceutical Inc. 48 BMRN	USD 14.51	Sept. 30, 2024	USD 63.81	-4.75%	United States
49	Moderna, Inc. 49 MRNA	USD 13.25	Sept. 30, 2024	USD 34.46	-1.96%	United States
50	Agrify Corporation 50 AGFY	USD 13.11	Sept. 30, 2024	USD 24.76	7.79%	United States

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Revenue Per Share ?

The Biotechnology company in United States with the highest Revenue Per Share is Cingulate Inc. (NasdaqCM: CING) at USD 68,343.25.
Which Biotechnology company in United States has the lowest Revenue Per Share ?

The Biotechnology company in United States with the lowest Revenue Per Share is Telomir Pharmaceuticals, Inc. Common Stock (NasdaqCM: TELO) at USD 0.00.

What are the top 10 Biotechnology companies in United States by Revenue Per Share ?

The top 10 Biotechnology companies in United States by Revenue Per Share are Cingulate Inc., Laboratory Corporation of America Holdings, Regeneron Pharmaceuticals, Inc., Thermo Fisher Scientific Inc., Radius Health, Inc., Bio-Rad Laboratories, Inc., IQVIA Holdings Inc., Charles River Laboratories International, Inc., Biogen Inc. and Amgen Inc..
What are the bottom 10 Biotechnology companies in United States by Revenue Per Share ?

The bottom 10 Biotechnology companies in United States by Revenue Per Share are Telomir Pharmaceuticals, Inc. Common Stock, Tharimmune, Inc., Apogee Therapeutics, Inc., Annovis Bio, Inc., Anebulo Pharmaceuticals, Inc., Kodiak Sciences Inc., GT Biopharma, Inc., Immunic, Inc., JUPITER NEUROSCIENCES, INC. and Disc Medicine, Inc..